Key Finding
Acupuncture significantly reduced menopause symptoms in breast cancer patients for at least 3 months after treatment ended, though it did not produce significant long-term maintenance effects on hot flush frequency or severity.
If you are a breast cancer survivor dealing with hot flashes and menopause symptoms caused by your treatment, you are not alone. Many women experience these uncomfortable changes as a side effect of hormone-blocking therapies or chemotherapy. Researchers wanted to find out whether acupuncture could offer lasting relief — and how long any benefits might stick around after treatment ends.
A team of scientists reviewed 13 high-quality clinical trials involving 943 breast cancer patients. They looked specifically at what happened after the acupuncture sessions were finished, asking: do the benefits last?
The results were encouraging, with an important nuance. Acupuncture did not show a strong long-term effect on hot flash frequency or severity on its own. However, it did significantly reduce broader menopause symptoms — things like sleep disturbances, mood changes, and physical discomfort — for at least three months after the final treatment session.
This matters because many breast cancer patients cannot or prefer not to use hormone replacement therapy due to safety concerns related to their diagnosis. Acupuncture offers a non-hormonal option with no adverse events reported across any of the studies reviewed.
The researchers also suggest a practical strategy: consider a follow-up acupuncture session around the three-month mark after your initial course of treatment. This booster approach may help extend the benefits and keep menopause symptoms better managed over time.
While more large-scale research is still needed to fine-tune the ideal treatment schedule, the existing evidence gives real reason for optimism. Acupuncture appears to be a safe, meaningful option for breast cancer survivors navigating the challenging hormonal changes that often accompany their treatment journey.
If you are interested in exploring acupuncture, speak with your oncology team and seek out a licensed acupuncturist with experience in oncology support care.
This systematic review and meta-analysis evaluated the maintenance effect of acupuncture on breast cancer treatment-related menopausal symptoms across 13 RCTs (n = 943), following PRISMA guidelines and Cochrane criteria, with analysis via RevMan 5.2. Seven databases were searched through February 2019 with no language restrictions. Results demonstrated that acupuncture produced no statistically significant long-term maintenance effect on hot flush frequency (p = 0.29) or severity (p = 0.34). However, a statistically significant 3-month post-treatment maintenance effect was observed for broader menopausal symptom amelioration (p = 0.001). No adverse events were reported across included trials. Clinical takeaway: acupuncture may serve as a viable non-hormonal adjunct for breast cancer patients contraindicated for or declining hormone therapy. A structured booster session at 3 months post-treatment should be considered to sustain symptomatic benefit. Larger trials are warranted to establish optimized treatment protocols.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Heat-sensitive moxibustion combined with intrapleural cisplatin achieved a 65% clinical effective rate versus 30% for cisplatin alone, while also significantly reducing bone marrow suppression from 55% to 15% and gastrointestinal reactions from 65% to 30%.
📌 A systematic appraisal of 15 RCTs and 10 systematic reviews found that the methodological quality of existing research on acupuncture for hot flashes and musculoskeletal symptoms in breast cancer patients is too poor to draw reliable conclusions about its effectiveness.
📌 Traditional acupuncture reduced hot flash severity scores by an average of 1.89 points in breast cancer patients compared to just 0.16 points with sham acupuncture, a statistically significant difference (P=.0064) with effects sustained at one-month follow-up.